PERINDOPRIL TERT-BUTYLAMINE/AMLODIPINE HCS Ireland - English - HPRA (Health Products Regulatory Authority)

perindopril tert-butylamine/amlodipine hcs

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablets - 4mg/5mg milligram - perindopril and amlodipine

PERINDOPRIL TERT-BUTYLAMINE/AMLODIPINE HCS Ireland - English - HPRA (Health Products Regulatory Authority)

perindopril tert-butylamine/amlodipine hcs

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablets - 4mg/10mg milligram - perindopril and amlodipine

PERINDOPRIL TERT-BUTYLAMINE/AMLODIPINE HCS Ireland - English - HPRA (Health Products Regulatory Authority)

perindopril tert-butylamine/amlodipine hcs

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablets - 8mg/10mg milligram - perindopril and amlodipine

Perindopril tert-butylamine/amlodipine HCS 8 mg/5 mg tablets Ireland - English - HPRA (Health Products Regulatory Authority)

perindopril tert-butylamine/amlodipine hcs 8 mg/5 mg tablets

hcs bvba - perindopril tert-butylamine; amlodipine besilate - tablet - 8mg/5mg milligram(s) - ace inhibitors and calcium channel blockers; perindopril and amlodipine

APO-Perindopril Arginine/Amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: colloidal anhydrous silica; croscarmellose sodium; microcrystalline cellulose; magnesium stearate - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/5 perindopril arginine 10 mg and amlodipine (as besilate) 5 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg) - tablet - excipient ingredients: microcrystalline cellulose; magnesium stearate; croscarmellose sodium; colloidal anhydrous silica - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-Perindopril Arginine/Amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 10/10 perindopril arginine 10 mg and amlodipine (as besilate) 10 mg uncoated tablet bottle

arrotex pharmaceuticals pty ltd - perindopril arginine, quantity: 10 mg; amlodipine besilate, quantity: 13.87 mg (equivalent: amlodipine, qty 10 mg) - tablet - excipient ingredients: croscarmellose sodium; colloidal anhydrous silica; magnesium stearate; microcrystalline cellulose - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.

APO-PERINDOPRIL/AMLODIPINE TABLET Canada - English - Health Canada

apo-perindopril/amlodipine tablet

apotex inc - perindopril arginine; amlodipine (amlodipine besylate) - tablet - 7mg; 5mg - perindopril arginine 7mg; amlodipine (amlodipine besylate) 5mg - angiotensin-converting enzyme inhibitors

APO-PERINDOPRIL/AMLODIPINE TABLET Canada - English - Health Canada

apo-perindopril/amlodipine tablet

apotex inc - perindopril arginine; amlodipine (amlodipine besylate) - tablet - 14mg; 10mg - perindopril arginine 14mg; amlodipine (amlodipine besylate) 10mg - angiotensin-converting enzyme inhibitors

APO-Perindopril Arginine/Amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack Australia - English - Department of Health (Therapeutic Goods Administration)

apo-perindopril arginine/amlodipine 5/5 perindopril arginine 5 mg and amlodipine (as besilate) 5 mg uncoated tablet blister pack

arrotex pharmaceuticals pty ltd - amlodipine besilate, quantity: 6.94 mg (equivalent: amlodipine, qty 5 mg); perindopril arginine, quantity: 5 mg - tablet - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; magnesium stearate; croscarmellose sodium - perindopril arginine and amlodipine combination tablet is indicated as substitution therapy for the treatment of hypertension and/or stable coronary heart disease in patients already controlled with separate doses of perindopril and amlodipine, given concurrently at the same dose level. treatment should not be initiated with this combination.